Literature DB >> 30190130

CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway.

Minnan Wang1, Bo Chen2, Zixuan Ru1, Li Cong3.   

Abstract

While recent evidence has uncovered that circular RNAs (circRNAs) are vital regulators of carcinogenesis, their role in papillary thyroid cancer (PTC) is not clearly understood. In this study, we reveal that lower levels of circRNA circ-ITCH are expressed in PTC tissues than in normal adjacent tissues. Gain-of-functional assays show that circ-ITCH overexpression suppresses PTC cell proliferation and invasion and promotes apoptosis in vitro. Overexpression of circ-ITCH also leads to impaired tumor growth in vivo. Bioinformatics analysis and luciferase reporter assays demonstrate that circ-ITCH sponges miR-22-3p to upregulate the expression of CBL, an E3 ligase of nuclear β-catenin. Elevated levels of CBL suppress activation of the Wnt/β-catenin pathway and consequently attenuates PTC progression. In summary, our study reveals a novel signaling pathway of circ-ITCH/miR-22-3p/CBL/β-catenin involved in PTC development and progression.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circ-ITCH; Circular RNA; Papillary thyroid cancer; Progression

Mesh:

Substances:

Year:  2018        PMID: 30190130     DOI: 10.1016/j.bbrc.2018.08.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  52 in total

1.  Circular RNA circ_ASAP2 promotes cell viability, migration, and invasion of gastric cancer cells by regulating the miR-770-5p/CDK6 axis.

Authors:  Bing Chen; Fei Ji; Xinian Wen; Zhong Jin
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

2.  Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression.

Authors:  Chunlei Nie; Jihua Han; Wen Bi; Zhilin Qiu; Lili Chen; Jiawei Yu; Rui Pang; Bo Liu; Ruinan Sheng; Jiewu Zhang
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

Review 3.  Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.

Authors:  Qian Bai; Zhenjie Pan; Ghulam Nabi; Farooq Rashid; Yang Liu; Suliman Khan
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 4.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

5.  The Use of circRNAs as Biomarkers of Cancer.

Authors:  Carla Solé; Gartze Mentxaka; Charles H Lawrie
Journal:  Methods Mol Biol       Date:  2021

Review 6.  The emerging function and clinical significance of circRNAs in Thyroid Cancer and Autoimmune Thyroid Diseases.

Authors:  Yu Zhang; Dong-Dong Jia; Yi-Fei Zhang; Meng-Die Cheng; Wen-Xiu Zhu; Pei-Feng Li; Yin-Feng Zhang
Journal:  Int J Biol Sci       Date:  2021-04-17       Impact factor: 6.580

7.  Downregulation of hsa_circ_0001681 suppresses epithelial-mesenchymal transition in thyroid carcinoma via targeting to miR-942-5p/TWIST1 signaling pathway.

Authors:  Tianyi Wang; Yinpeng Huang
Journal:  J Bioenerg Biomembr       Date:  2021-06-23       Impact factor: 2.945

8.  Circ_0137287 suppresses cell tumroigenesis and aerobic glycolysis in papillary thyroid carcinoma through miR-183-5p/PPP2R2A axis.

Authors:  Jingjing Ma; Zhenghua Kan
Journal:  Cytotechnology       Date:  2021-05-13       Impact factor: 2.040

9.  Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells.

Authors:  Hui Xiong; Jinsong Yu; Guangwei Jia; Yang Su; Jianliang Zhang; Qiu Xu; Xiaoxiong Sun
Journal:  Hum Cell       Date:  2021-08-03       Impact factor: 4.374

10.  Circular RNA circWDR27 Promotes Papillary Thyroid Cancer Progression by Regulating miR-215-5p/TRIM44 Axis.

Authors:  Weilan Wang; Chengmin Huang; Peng Luo; Jiang Yao; Jie Li; Wenxia Wang; Fengqin Liu
Journal:  Onco Targets Ther       Date:  2021-05-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.